Harrington Discovery Institute at UH Opens Call for 2021 Harrington Scholar-Innovator Award
Program for physician-scientists to progress promising discoveries toward clinical trials
February 28, 2020, CLEVELAND, Ohio USA – The 2021 Harrington Scholar-Innovator Award is now open and accepting Letters of Intent. The award offers inventive physician-scientists resources and expertise to advance their discoveries into medicines. Intellectual property rights are retained by the award recipient or his or her institution. Up to 10 applicants will be selected to receive:
- $100,000 guaranteed; opportunity to qualify for up to $700,000.
- Dedicated drug discovery and development support from Harrington Discovery Institute’s Therapeutics Development Team (pharma-experienced industry leaders with a track record of bringing drugs to market).
- A personalized team of drug developers and project manager for every scholar.
The competition is open to physician-scientists at accredited academic medical centers, research institutions and universities in the United States and Canada. Selection criteria include innovation, creativity and potential for impact on human health. Applicants must have a doctorate in medicine. Award recipients will be selected by the Harrington Discovery Institute’s Scientific Advisory Board and announced in December 2020.
The deadline to submit a Letter of Intent is March 27, 2020 at 11:59 PM EDT. The full application deadline, for those invited to submit, is May 15, 2020.
Past and current Harrington Scholar-Innovators share their experiences and the positive impact the program has had on their drug discoveries in these short videos. Learn more and apply to the 2021 Harrington Scholar-Innovator Award at www.HarringtonDiscovery.org/Grant.